Skip to main content

Together we are beating cancer

Donate now

Tim Gunn

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.
Showing 12 out of 76 results
A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

Pictures of Taylor, Zaid and Eilidh in hospital during their cancer treatment.

Four teenagers and young adults tell us what it's like to receive a lifechanging cancer diagnosis while your life is still taking shape. Four teenagers and young adults tell us what it's like to receive a lifechanging cancer diagnosis while your life is still taking shape.

by Tom Bourton, Tim Gunn | Personal stories | 4 April 2025

4 April 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Science & Technology
  • Health & Medicine
  • Charity News

Our Teenage and Young Adult Cancer Awareness Month research roundup

Around 2,200 teenagers and young adults are diagnosed with cancer in the UK every year. For Teenage and Young Adult Cancer Awareness Month, we're highlighting some of the ways we're working to help them. Around 2,200 teenagers and young adults are diagnosed with cancer in the UK every year. For Teenage and Young Adult Cancer Awareness Month, we're highlighting some of the ways we're working to help them.

by Ben Sammon, Tim Gunn | In depth | 26 March 2025

26 March 2025

Lung cancer cells seen through a microscope, in shades of purple and green,

Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer. Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer.

by Tim Gunn | News | 5 March 2025

5 March 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

A man in a bathroom opening a bowel cancer screening test kit (FIT kit) from NHS England.

NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years. NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years.

by Tim Gunn | News | 14 January 2025

14 January 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Science & Technology
  • Health & Medicine
  • Charity News

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

by Sadaf Shafaghmotlagh, Tim Gunn | In depth | 17 December 2024

17 December 2024

Dr Yin Cao and a colleague looking at data about cancer incidence.

Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund.

by Tim Gunn | News | 11 December 2024

11 December 2024